Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIVAROXABAN vs RIVASTIGMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIVAROXABAN vs RIVASTIGMINE: Safety Overview

Metric RIVAROXABAN RIVASTIGMINE
Total FAERS Reports 131,274 9,123
Deaths Reported 19,233 2,232
Death Rate 14.7% 24.5%
Hospitalizations 70,513 2,716
Average Patient Age 70.0 yrs 80.0 yrs
% Female Patients 47.7% 59.5%
FDA Approval Date Apr 10, 2025 Apr 21, 2000
Manufacturer Macleods Pharmaceuticals Limited Novartis Pharmaceuticals Corporation
Route ORAL TRANSDERMAL
Marketing Status Prescription Discontinued